EUVIMEDEUVIMED entdecken
Crossref

Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry

M Duran-Martínez, M Bergillos-Giménez, L Rodríguez-Ortíz, A Arjona-Sánchez, Laparoscopic PSOGI Registry

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von M Duran-Martínez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain. Hauptthemen laut MEDLINE: Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy, Laparoscopy, Peritoneal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are established treatments for peritoneal surface malignancies, traditionally performed via laparotomy. Recent advancements in laparoscopic approaches (L‐CRS + HIPEC) have shown promising results in selected patients.

Methods

The PSOGI registry, established in November 2019, collects data from specialized centers performing L‐CRS + HIPEC. Data were collected prospectively and analyzed retrospectively, excluding risk‐reducing procedures without peritoneal disease. The learning curve was assessed using a 14‐cases cutoff.

Results

Today, 323 patients have been registered, 193 were included finally. Perioperative outcomes improved after 14 cases: Length of hospital stay was 7.78 ± 3.64 days (consolidation) versus 8.8 ± 8.79 days (learning) and major morbidity was 0% (consolidation) versus 5% (learning), ( p = n.s.). Estimated blood loss was lower in the consolidation phase. Oncological outcomes also improved: Recurrence rate was 8.7% (consolidation) versus 17.8% (learning). Disease‐free survival 5 years, 65% (learning) versus 88% (consolidation) ( p = 0.012).

Conclusion

The L‐CRS + HIPEC is a safe procedure with non‐inferior oncologic outcomes which it is evaluating in an IDEAL setting by an international group. The validation of the learning curve, gives us the knowledge that a mentoring program must be setup to reduce the learning curve impact in oncologic failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyLaparoscopyPeritoneal NeoplasmsHumansRegistriesFemaleMaleMiddle AgedRetrospective StudiesAgedAdultCombined Modality TherapyLearning CurveProspective StudiesSurvival RateFollow-Up Studies

Stichwörter der Autor:innen

HIPECcytoreductionlaparoscopyperitoneal carcinomatosis

Autor:innen und Institutionen

  • Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain.
  • Department of Biochemistry and Molecular Biology, GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, U…

Zitieren

APA

Duran-Martínez, M., Bergillos-Giménez, M., Rodríguez-Ortíz, L., Arjona-Sánchez, A., & Laparoscopic PSOGI Registry (2024). Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27881

Vancouver

Duran-Martínez M, Bergillos-Giménez M, Rodríguez-Ortíz L, Arjona-Sánchez A, Laparoscopic PSOGI Registry. Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27881

BibTeX
@article{DuranMartnez2024,
  author = {Duran-Martínez, M and Bergillos-Giménez, M and Rodríguez-Ortíz, L and Arjona-Sánchez, A and Laparoscopic PSOGI Registry, Laparoscopic PSOGI Registry},
  title = {Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27881}
}
Kostenlos starten →